Optimized sequence of drug administration and schedule leads to improved dose delivery for gemcitabine and paclitaxel in combination: a phase I trial in patients with recurrent ovarian cancer
C. J. Poole, T. Perren, S. Gawande, M. Ridderheim, J. Cook, A. Jenkins, D. Roychowdhury
International Journal of Gynecologic Cancer Mar 2006, 16 (2) 507-514; DOI: 10.1136/ijgc-00009577-200603000-00008